Path:
Home >
GB/T >
Page595 > GB/T 44467-2024
Price & Delivery
US$364.00 · In stock · Download in 9 secondsGB/T 44467-2024: Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated human DNA
Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See
step-by-step procedureStatus: Valid
| Std ID | Version | USD | Buy | Deliver [PDF] in | Title (Description) |
| GB/T 44467-2024 | English | 364 |
Add to Cart
|
4 days [Need to translate]
|
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated human DNA
|
Click to Preview a similar PDF
Basic data
| Standard ID | GB/T 44467-2024 (GB/T44467-2024) |
| Description (Translated English) | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated human DNA |
| Sector / Industry | National Standard (Recommended) |
| Classification of Chinese Standard | C30 |
| Classification of International Standard | 11.100.10 |
| Word Count Estimation | 18,155 |
| Date of Issue | 2024-09-29 |
| Date of Implementation | 2025-04-01 |
| Issuing agency(ies) | State Administration for Market Regulation, China National Standardization Administration |
GB/T 44467-2024: Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated human DNA
---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated human DNA
Molecular in vitro diagnostic test before saliva test
Standardization of the process for extracting human DNA
Molecular in vitro diagnostic examinations-Specifications for pre-examination
processes for saliva-Isolated human DNA
(ISO 4307.2021, IDT)
ICS 11.100.10
CCS C 30
National Standard of the People's Republic of China
Released on 2024-09-29
2025-04-01 Implementation
State Administration for Market Regulation
The National Standardization Administration issued
Table of Contents
Preface ... Ⅲ
Introduction ... Ⅳ
1 Scope ... 1
2 Normative references ... 1
3 Terms and Definitions ... 1
4 General requirements ... 4
5 Outside the laboratory ... 4
5.1 Specimen Collection 4
5.2 Shipping Requirements 6
6 Inside the laboratory ... 6
6.1 Specimen Preparation 6
6.2 Storage requirements 7
6.3 Isolation of saliva DNA 7
6.4 Qualitative and quantitative evaluation of DNA 8
6.5 DNA Storage 8
References ... 10
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1.Structure and drafting rules for standardization documents"
Drafting is required.
This document is equivalent to ISO 4307.2021 "Specification for pre-testing procedures for molecular in vitro diagnostic tests - Extraction of saliva from human
DNA".
Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents.
This document is proposed by the State Food and Drug Administration.
This document is under the jurisdiction of the National Technical Committee for Standardization of Medical Clinical Testing Laboratories and In Vitro Diagnostic Systems (SAC/TC 136).
This document was drafted by. Peking University People's Hospital, Peking University International Hospital, Beijing Institute of Medical Device Inspection (Beijing Medical
Biological Protection Equipment Inspection and Research Center), Beijing Hospital, Shanghai Clinical Laboratory Center, Shenzhen MGI Technology Co., Ltd.
The main drafters of this document are. Zhao Xiaotao, Sun Yujing, Xu Songyan, Xiao Fei, Xiao Yanqun, Hou Xiaodan and Wan Xinxin.
Introduction
Medicine has made great progress due to the development of molecular in vitro diagnostic technology. Analyze nucleic acids, proteins and metabolic substances in human tissues and fluids
New technologies that detect and analyze biomarkers hold great promise for further advances in medicine. However, the behavior of these molecules varies greatly during specimen collection, transportation, storage, and processing.
The condition may change significantly, making the diagnosis or research results unreliable or even impossible to analyze.
The analytical tests cannot reflect the patient's true condition.
Saliva contains microorganisms and foreign matter (eg, food particles), making the composition of a patient's or donor's saliva more complex and unique.
Therefore, it is necessary to explain the pre-collection preparations to patients or donors before collection and check whether they comply with them to reduce the variability of specimens.
Medical laboratories/IVD manufacturers need to be aware of specimen variability when performing validation and confirmation designs.
The DNA in saliva may become fragmented or degraded. In addition, bacteria in saliva samples can continue to grow and
Dilute human DNA. The deoxyribonucleases secreted by these bacteria can also accelerate DNA degradation. All of these may affect DNA testing.
Sensitivity and reliability.
The entire process from specimen collection to DNA testing needs to be standardized to minimize factors such as DNA degradation and fragmentation after saliva collection.
This document contains the information required to obtain high-quality saliva specimens/samples and isolate human DNA from them for testing.
Special measures to be taken.
Molecular in vitro diagnostic test before saliva test
Specification of the process for extracting human DNA
1 Scope
This document specifies how sputum intended for human DNA testing should be handled, stored, processed and recorded during the pre-test phase of molecular testing.
The requirements for liquid specimens are given and corresponding recommendations are provided.
This document applies to molecular in vitro diagnostic tests, including laboratory-developed tests performed by medical laboratories and molecular pathology laboratories;
For laboratory customers, in vitro diagnostic developers and manufacturers, biobanks, institutions and commercial organizations engaged in biomedical research, and
Regulatory bodies.
This document does not cover the specific measures required for collecting saliva into absorbent materials or by gargling, as well as the storage and handling of saliva.
Measures of cell-free DNA in fluid, DNA of pathogens and other bacteria, or the entire microbiome.
2 Normative references
The contents of the following documents constitute the essential clauses of this document through normative references in this document.
For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies.
in this document.
ISO 15189 Medical laboratories - Requirements for quality and competence
competence
Note. GB/T 22576.1-2018 Requirements for quality and competence of medical laboratories Part 1.General requirements (ISO 15189.2012, IDT)
ISO 15190 Medical laboratories-Requirements for safety
Note. GB 19781-2005 Safety requirements for medical laboratories (ISO 15190.2003, IDT)
3 Terms and definitions
For the purposes of this document, the terms and definitions defined in ISO 15189 and the following apply.
3.1
Ambient temperature
The temperature of the unconditioned ambient air.
[Source. GB/T 42080.1-2022, 3.2]
3.2
Analyte
The component represented by the name of the measured quantity.
[Source. GB/T 21415-2008, 3.2, modified]
3.3
Analytical test performance
The ability of a test procedure to measure or detect a specific analyte (3.2).
NOTE. Other test performance characteristics such as robustness, repeatability, etc. are also included.
[Source. GB/T 42080.1-2022, 3.4, modified]
...
